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SU M M A R Y
In ihc C ity  o f  G w c ru  m e a s le s  v a c c in a tio n  w as 
co m m en ced  in  1 9 7 1 . W ith  th e  a d v e n t  o f  th e  
Expanded P rog ram m e o n  Im m un isa tion  in 1 9 8 1 -8 2 , 
m easles  v a c c in a t io n  c o v e r a g e  w a s  in c re a s e d ,  
reaching ov er 80 pc in 1985 an d  after. D esp ite  th is 
vaccination e ffo r t  m e a s le s  m o rb id ity  ra te s  h av e  
rem ained h igh  an d  ep id e m ics  co n tin u e  to  o ccu r 
periodically. It is  a rg u ed  th a t the  sh ift o f  the d isease 
from young age g ro ups to o ld er ch ild ren , coup led  
with the fact tha t there a re  m ore vaccinccs am ongst 
cases w ith the d isease , w ill m ean  tha t transm ission  
will con tinue u n in te rru p ted . P o ss ib le  reaso n s  for 
persistent transm ission  in o ld er ch ild ren  arc  exp lo red . 
It is concluded that m easles  rcv acc in a tion  is requ ired  
to interrupt m easles  transm ission .
IN T R O D U C T IO N
W orld-wide an  es tim ated  tw o m illion  ch ild ren  d ie 
from m easles and its co m p lica tio n s  every  y ear.1 
S evere  m e a s le s  is  l im i te d  g e o g r a p h ic a l ly  to  
developing coun tries  w h ere  it is unquestionab ly  one
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o f  the  m o st p rev a len t and  serious in fec tiou s d iseases 
o f  c h i ld h o o d /  T h is  g ru e s o m e  e p id e m io lo g ic a l  
p ic tu re  has p rov id ed  a  strong  p riori case  fo r m easles 
p rev en tio n  th rough  im m unisa tion .
In the C ity  o f  G w eru  in Z im b ab w e , vaccination  
ag a in st m easles  w as co m m en ced  in 1971, g a ined  
m o m en tu m  in the  late sev en ties  an d  w as acce le ra ted  
and  co nso lid a ted  w ith the  ad v en t o f  the E xpand ed  
P rog ram m e on  Im m u n isatio n  (E P I) in 1982-83 . In 
th is  p ap er w e shall ex am in e  how , d esp ite  ag g ress iv e  
e f f o r t s  a im e d  a t  c o n t r o l l in g  m e a s le s  th ro u g h  
v acc in a tio n , it w ou ld  n o t b e  p o ss ib le  to  in te rru p t 
m easles  transm ission  w ith  the  s in g le  n in e  m o n th s  o f 
ag e  vaccination  reg im e , due  to  the  ch an g in g  ag e  
ep idem io lo g y  o f  the  d isease .
M A TE R IA LS A N D  M E T H O D S
T h is  study  w as carried  o u t in th e  C ity  o f  G w eru , the  
th ird  largest c ity  in Z im b ab w e w ith  a  to tal p opu la tio n
o f  110 000  people.
In G w eru  m easles vaccination  is done  as p a rt o f  the 
E PI effort. A  sing le  d o se  o f live  hypera ttenu a ted  
S chw arz  strain  v acc in e  (0 .5m ls o r 1000 T C ID 5 0 ) is 
a d m in is te re d  to  in fa n ts  a t n in e  m o n th s  o f  age . 
S u rve illance  o f  im m unisa tion  ac tiv ities  (inc lud ing  
m easles m orb id ity  and  m orta lity  data) is m anaged  
th roug h  reco rd s an d  d isease  reg isters  o f  the  rou tine  
h e a lth  in fo rm a tio n  s y s te m . T h e  d a ta  in d ic a te d  
h ereu n der a re  ex trac ted  from  this source.
R ESU LTS
M easles vaccination  in the u nder fives rose  from  1.8 
pc in  1971 to 90 .7  pc in 1989, a fifth  fo ld  inc rease  in 
an  18 year p erio d . C o m m en cem en t o f  the E P I in 
1 9 81 -8 2  b ro u g h t fo rth  a  r is e  in th e  v acc in a tio n  
co v erag e  from  66  p c  in  1982 to  91 p c  in 1989. (S ee  
T able 1 and F igure  1).
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Table 1: Measles immunisation (overage in the age 
group 0-5 years
Year 1971 1 9 7 5 1 9 7 9 1 9 8 0 1981 1 9 8 5 1 9 8 8 1 9 8 9
Population 
0 -  years 1 1 4 5 9 1 1 0 5 7 1 2 4 7 6 1 3 9 4 3 1 5 8 6 7 2 6 3 0 2 2 3 8 8 4 1 8 9 3 3
Population
vaccinated 2 0 3 3 1 7 7 7 1 8 6 8 3 5 0 1 0 2 5 9 2 2 5 6 1 2 0 1 3 5 1 7 1 6 8
pc
Coverage 1 ,7 8 2 8 ,7 3 5 6 .3 8 6 3 ,4 7 6 4 ,6 6 8 5 .7 3 8 4 .3 0 9 0 .6 8
M easles  m o rta lity  ra te  has dec lined  from  an  all 
h igh  o f  115/1000  0 00  popu la tio n  in 1968 to  zero  in 
1 9 8 9 . A  s te a d y  d e c l in e  in  m e a s le s  m o r ta l i ty  
co m m en ced  from  1970. B y 1980 the  m orta lity  rate 
had d w in d led  to 6 /1 0 0  0 0 0  pop u la tio n . (S ee  T able II 
and  F ig u re  II).
M easles  ep idem ics  co n tin u e  to  o ccu r perio d ica lly  
a n d  t h e i r  m a g n i t u d e  r e s e m b l e s  t h a t  o f  th e
p re -im m u n isa tio n  era . A n n ua l in c id en ce  ra te s  o f  
m easles  rem ain  h igh. (S ee  T able III and  F igure III) 
T able IV  rep resen ts  the ag e  d istrib u tio n  o f  cases o f 
m easles  b e tw een  1968 and  1989. F ro m  1968 to  1989 
the  age  g ro u p  0 - 9  m o n th s’ con trib u tio n  to  the an nu a l 
in c id en ce  o f  m easles  has v aried  b e tw een  4  p c  and  12 
pc. In  th e  21 y ea r p erio d  to  1989 th e  age  g ro u p ’s 
a n n u a l  c o n tr ib u t io n  to  m e a s le s  in c id e n c e  h a s  
av erag ed  8 p c  (S ee T able V)
B e tw ee n  1968  an d  1983 th e  a g e  g ro u p  0 -2 3  
m o n th s  d o m in a ted  th e  m o rb id ity  p ic tu re . In  this 
p e rio d  th e  a g e  g ro u p  a c c o u n te d  fo r  o v e r 50  pc 
m easles  cases  annually . T h e  fo u r y ea r  p e rio d  1983 to 
1986 rep resen ts  a  transitional p h ase  in  w hich  the 
p ro portion  o f  ca se s  occu rrin g  am o n g st o ld e r  ch ild ren  
o f  6 0  m on th s o f  ag e  and  o v e r b eg in s  to  increase  and  
this fea tu re  is w ell es tab lish ed  a fte r 1988, w ith  this
Table 11: Measles Mortality —  annual mortality, mortality rales and fatality rates (Disease specific mortality, 
mortality rates and fatality rates
Year 1961 1964 1967 1968 1970 1971 1974 1975 1977
Total Population 27283 40851 44588 45376 46172 48631 57569 59777 64840
Annual measles deaths 
Annual measles mortality rate per
5 24 49 52 26 17 14 3 5
100 000 population 13 59 110 115 56 35 24 5 8
Measles fatality rate per 100 cases 8 22 48 38 25 15 6 6 2
Year 1979 1980 1981 1982 1983 1986 1987 1988 1989
Total Population 66381 69786 74181 76955 81648 99055 102350 105532 108671
Annual measles deaths 
Annual measles mortality rate per
10 4 2 3 11 0 0 1 0
100 000 population 15 6 3 4 13 0 0 1 0
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Figure II: Measles disease-specific mortality rate per 100 000 population
\
\
table III: Measles-annual incidence and incidence rate (Disease specific morbidity in the total population)
Year 1947 1950 1955 1959 1960 1964 1967 1970 1975 1979
Total population 28055 30035 33079 35729 36577 40851 41588 48631 59777 66381
Annual incidence 
Incidence rate per
107 26 2 10 41 109 83 103 52 210
100 000 population 381 87 6 28 112 198 231 212 87 316
Year 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989
Total population 69786 76955 76955 81648 89715 95310 99055 102350 105532 108671
Annual incidence 
Incidence rate per
91 115 244 418 50 527 356 267 271 164
100 000 population 130 155 317 512 56 553 359 261 257 151




age g rou p  acco u n tin g  fo r 59 pc o f  m easles  cases 
annually .
D ata  on vacc in a tio n  sta tus o f  cases is  av a ilab le  
from  1980 (S ee T able V II) B y  1982 the  ag e  g rou p  
1 0 - 5 9  m o n t h s  h a d  m o r e  v a c c i n a t e d  th a n  
u n vacc ina tcd  cases , 59 pc an d  41 p c  respective ly . 
T h is p h en o m en o n  o ccu rred  tw o  years  la te r in  1984 
fo r  th e  a g e  g r o u p  6 0 - 1 1 9  m o n th s  w h e n  th e
v acc in a ted  cases  accou n ted  for 6 0  p c  o f  ca se s  w hile  
the  u n v acc in a ted  accou n ted  fo r 4 0  pc cases.
B o th  ag e  g ro u p s h av e  s in ce  then  reg iste red  m o re  
v acc in a ted  cases  than  u nvacc ina ted . T h e  ag e  g ro u p  
120 m onths p lu s, a ltho u g h  it h as c o n tr ib u ted  n o  m ore  
than 13 p c  to  m easles  annual in c id en ce  in  an y  o n e  
year, has in  th e  p a s t  10 -year p e rio d  co n tr ib u ted  m ore  
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Table IV: Measles annual incidence by age group
Age Groups (in months)
Year 0-9 0-1 12-23 24-35
1968 8 26 56 16
1970 7 15 39 10
1971 5 17 36 13
1975 2 11 23 5
1979 10 28 67 24
1980 12 15 46 23
1981 10 22 48 7
1982 22 36 95 32
1984 5 9 11 13
1985 54 72 87 78
1987 20 28 45 19
1988 19 31 27 25
36-47 48-59 60-71 72-83 84-95
18 11 2 4 0
11 4 2 2 6
10 7 4 4 4
3 3 3 2 0
16 15 8 13 14
11 3 6 6 1
7 4 3 5 6
27 11 9 9 5
5 4 4 7 0
65 62 37 30 18
26 21 25 40 25




2 0 3 138
3 3 8 103
4 4 11 114
0 0 2 52
5 3 17 210
2 3 10 126
2 4 7 115
6 3 11 244
0 0 2 49
25 11 52 527
10 7 21 267
23 11 17 271
D IS C U S S IO N
In G w cru  the  m easles m ortality  ra te  has d ec lined  
d ram atically . G o in g  by  ex p erien ce  e lsew h ere  it can  
no t b e  d o u b ted  tha t im m un isa tion  has p layed  a  ro le3in du s decline .
W h at has vexed  us is tha t d esp ite  a  h ig h  m easles 
v acc in a tion  co v erag e  and  a  rosy m o rta lity  p ic tu re , 
m easles m orb id ity  ra tes  a rc  unyield ing . T h is  w e have 
u nders to o d  to  m ean  that th e  d eg ree  o f  ex p o su re  and 
su scep tib ility  o f  the ch ild  p opu la tio n  to the d isea se  
has rem ained  the  sam e o v er the years.
In  so m e  d e v e lo p in g  c o u n tr ie s  th e  a g e  g ro u p  
z e ro -n in e  years has been  re spo nsib le  fo r h igh  ra tes 
o f  m easles  transm ission  to  a  p o in t w h ere  W H O  has 
r e c o m m e n d e d  t h a t  t h e  “ h ig h  l i t r e ”  
E d m o n s to n - Z a g r e b  (E Z )  m e a s le s  v a c c in e  b e  




0 -2 3  months





pc of annual 
Incidence
1968 138 82 59 11 8
1970 103 54 52 24 23
1971 114 53 47 31 27
1975 52 34 65 7 14
1979 210 95 45 60 29
1980 126 61 48 28 22
1981 115 70 61 27 24
1982 244 131 54 43 18
1984 49 20 41 7 14
1985 527 159 30 173 33
1987 267 73 27 128 48
1988 271 58 21 147 54
1989 164 37 23 89 54
Table V Measles incidence in the age group 0-9  
months (1968-1989)
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Table VIIMeasles annual incidence by age groups v.s vaccination status
Measles annual incidence by age groups in months and vaccination status




+ --- + _ + _ + --- + — + — + --- + — + — + — + — + ---
1980 12 2 1 12 34 1 22 2 9 1 2 4 2 4 2 0 1 0 2 0 3 2 8 126
1981 10 1 11 23 25 2 5 2 5 0 4 0 3 4 1 1 5 1 1 0 4 0 7 115
1982 22 11 3 52 43 18 14 17 10 8 3 4 5 4 5 2 3 3 3 2 1 4 7 244
1983 53 23 2 78 62 29 24 23 15 13 6 7 4 3 8 6 2 6 9 3 5 5 32 418
1984 5 3 1 5 6 10 3 3 2 2 2 2 2 1 0 0 0 0 0 0 0 0 2 49
1985 54 14 4 54 33 51 27 30 35 30 22 22 15 16 14 7 11 11 14 5 6 8 44 527
1986 31 13 7 37 17 30 13 29 9 27 9 26 14 23 5 11 8 4 7 3 3 5 25 356
1987 20 5 3 34 11 15 4 21 5 18 3 19 6 35 5 24 1 6 4 4 3 7 14 267
1988 19 8 4 17 10 14 11 13 5 18 5 23 3 30 18 15 7 16 7 4 7 3 14 271
1989 19 4 3 10 1 13 4 11 3 5 2 7 1 13 10 11 9 8 4 3 2 1 20 164
+=Vaccinated
—P o t vaccinated
Table VIII: Vaccination status of cases for the age groups 10-59 months, 60--119 months and 120 months+
(1980-1989)
Year 10-59 months 60-119 months 120 months+
No. of Vaccinated Unvaccinated No. of Vaccinated Unvaccinated No. of Vaccinated Unvaccinated
Cases No. pc No. pc Cases No. pc No. pc Cases No. pc No. pc
1980 86 18 (21) 68 (79) 18 8 (44) 10 (56) 10 2 (20) 8 (80)
1981 74 28 (38) 46 (62) 20 6 (30) 14 (70) 7 0 (0) 7 (100)
1982 179 106 (59) 73 (41) 32 13 (41) 19 (59) 11 4 (36) 7 (64)
1983 275 166 (60) 109 (40) 55 27 (49) 28 (51) 37 5 (14) 32 (86)
1984 37 23 (62) 14 (38) 5 3 (60) 2 (40) 2 0 (0) 2 (100)
1985 300 179 (60) 121 (40) 121 61 (50) 60 (50) 52 8 (15) 44 (85)
1986 191 136 (71) 55 (29) 104 67 (64) 37 (36) 30 5 (17) 25 (83)
1987 119 93 (78) 26 (22) 107 88 (82) 19 (18) 21 7 (33) 14 (67)
1988 105 70 (67) 35 (33) 130 88 (68) 42 (32) 17 3 (18) 14 (82)
1989 56 43 (77) 13 (23) 68 42 (62) 2 (38) 21 1 (5) 20 (95)
adm inistered  to in fan ts a t six  m onths o f  ag e  ’ 
O ccurrence o f  m easles  b efo re  the ag e  o f  n ine  m onths 
in infants is n o t a  p rob lem  o f  pub lic  health  im portance  
in our ex perience  M easles  stud ies carried  ou t in rural 
Z im babw e show  a s im ila r p ic tu re .6 O n accou n t o f  this 
we h av e  h ad  no  e p id e m io lo g ic a l im p e ra tiv e  to 
vaccine ch ild ren  b efo re  the age  o f  n ine  m onths.
We have w itn essed  an a lte red  age ch a rac te r o f  the 
disease. A n inc reas ing  and g rea te r p ro p o rtio n  o f  cases 
now o ccurs in  the  o ld e r ag e  g rou ps o f  60  m on ths o f  
age p lus, as op po sed  to  th e  trad itiona lly  ex p o sed  and  
susceptib le po pu la tio n  o f  23 m on ths o f  ag e  an d  under, 
who b o re  the  b ru n t o f  m easles  transm ission  p rio r to 
w idespread  m e a s le s  im m u n isa tio n . Im m u n isa tio n  
(particularly  h ig h  im m un isa tio n  co v erag e , b u t o f  less 
than 100 pc u p tak e , w h o se  ta rg e t ag e  g ro u p  has been  
children u nder tw o  years) is sa id  to  b e  resp o n sib le  for 
th is c h a n g e  in  th e  e p id e m io lo g ic a l  p a t te rn  o f
7m easles. A  sim ila r p ic tu re  has b een  o b se rv ed  in rural 
Z im b ab w e . 6 T h e  sh if t to  o ld e r  c h ild re n  in the  
transm ission  p a tte rn  o f  the  d isea se  is ex ace rb a ted  by 
the  fac t tha t th is  is  o ccu rrin g  to  a  sch o o l-g o in g  
p o p u la tio n  an d  sc h o o ls  a re  k n o w n  to  b e  fe rtile  
g ro u n d s  fo r tran sm issio n  o f  m easles .7
T h e  p ro p ortio n  o f  cases w hich  o ccu rs  am on g st 
p rev iou sly  v acc ina ted  ch ild ren  has been  increasing . 
T h is  is  a n  e x p e c t e d  c o n s e q u e n c e  o f  a  h ig h  
co v erag e .2,8 H ow ever, in  a  situa tion  lik e  o u rs  w here  
m orb id ity  ra te s  h av e  rem ained  h igh  in the  face  o f  a  
vaccination  e ffo rt am ou n tin g  to  a  co v erag e  o f  o v er 
80  p c  in  the  six  years  up  to  1989, m easles  cases 
occu rrin g  am o n g st vacc in ees a rc  suspec t. T h is  is 
particu la rly  so  w hen  co g n isan ce  is taken  o f  the fac t 
tha t they  h av e  con tin u ously  accoun ted  fo r o v e r 6 0  pc 
o f  cases  in  the  four y ea rs  to  1989 in both  the 10 -59  
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has g iv en  us reason  to  b e lieve  that vaccines arc 
s u p p o r t in g  t r a n s m is s io n  a n d  a re  c o n s e q u e n t ly  
fuelling  the po o l o f  susccp tib lcs.
E inn em ann  rep o rts  that in  som e stud ies m easles 
o ccu rrin g  in p rev io u s ly  vacc in a ted  ch ild ren  have 
c o n t r ib u t e d  s i g n i f i c a n t l y  to  p e r p e t u a t i o n  o f  
ep idem ics. In co m m un ity  o u tb reaks  from  four to 32 
pc o f eases have  inv o lv ed  v accinated  ch ild ren  and  in 
school ep id em ics  89 pc. W hen  v acc in e  efficacy  has 
been  d e te rm ined  in these  ep id em ics  it has ranged  
from  67 pc to 90  pc the overa ll vacc in e  e fficacy  has 
been  ab ou t 90  pc. 9 M ay be th is se t o f  c ircum stan ces 
ex p la in s  th e  m echan ism  by w hich  the  sh ift o f the 
d isease  to o ld e r  sch o o l-g o ing  ch ild ren  co n tr ib u tes  to 
m a in te n a n c e  an d  p e rp e tu a tio n  o f  h ig h  m e a s le s  
m o rb id ity  rates.
A n o th e r  e p id e m io lo g ic a l  p e c u lia r ity  w e h av e  
o b se rv ed  re la te s  to  an  in c rea s in g  o cc u rre n c e  o f  
p redo m in an tly  u n vacc ina tcd  eases ag ed  120 m onths 
and over. T h is ph en om en o n  has a lso  been  obse rved  
in  m e a s le s  s tu d i e s  c a r r i e d  o u t  in  th e  ru r a l  
Z im b ab w e .10 It co u ld  b e  th a t these  p eo p le  w ere 
spared  from  co n trac tin g  m easles  in early  ch ildhood  
due to  p ro tec tio n  from  herd  im m unity.
W h a t  a r e  th e  im p lic a tio n s  o f  th e se  f in d in g s?
1. A s ind icated  ea rlie r  w e d o  no t see the  need  to 
v acc in a te  any ch ild  ea rlie r than  n ine  m on ths o f  age.
2. A l th o u g h  th e r e  h a s  b e e n  a  s h i f t  in  th e  
tran sm issio n  o f  th e  d isea se  from  y o un g  to o ld er 
ch ild ren , the young  ch ild ren  (u n d er 23 m o n th s  o f  age) 
rep resen ted  23 pc o f all eases o f  the  d isea se  in 1989. 
T hus the ir level o f  co n tr ib u tio n  to  tran sm ission  o f  the 
d i s e a s e ,  w e  b e l i e v e ,  is  s u b s t a n t i a t e d  a n d  
c o n s e q u e n t ly  w e  w ill  m a in ta in  th e  p o lic y  o f  
vacc in a tin g  ch ild ren  a t n ine  m o n ths o f  age .
3. T h e  sh ift o f  the d isease  to  o ld e r  ch ild ren  m any 
o f  w hom  are  vacc in a ted  has m ean t to us th a t they arc 
no t ad eq u a te ly  p ro tec ted  by  the  sing le  n ine  m onth  
dose. W ith in  ou r ex p erien ce , the  o th er ch ildhood  
im m u n isab lc  c o n d itio n s  such  as  p e rtu ss is , po lio , 
d i p h t h e r i a  a n d  t e t a n u s ,  f o r  w h ic h  s e v e r a l  
vaccinations a re  requ ired  for each  ch ild  to e ffec t 
m ean in g fu l im m unity , have v irtually  d isap p eared  at 
a v acc in a tion  co v erag e  o f  o v e r 80  pc. G iven  this 
b ack g ro u n d  w e  h av e  h ad  rea so n  to  b e lie v e  that 
po ssib ly  d u e  to  c ith e r age a t vacc in a tion  (in  re la tion  
to m ate rna l an tibo dy  activ ity  a t n ine  m on ths o f  age)
o r h ypera tten uation  o f  the vacc ine  (or bo th ) w hen  w e 
v accin ate  them  young , the im m uno gcn ic ity  o f  the 
vacc ine  is com prom ised . As the ch ild ren  ad v an ce  in 
age th e ir im m un o cap ac ity  d ec lines and  co nseq uen tly  
ren d e rs  them  su sc ep tib le  to  in fec tio n . I t is thus 
possib le  that if  they w ere to be re v accinated , p ossib ly  
a t sch oo l entry , th e ir im m unocapac ity  w ould  im prove 
and this m ig h t in te rrup t m easles transm ission  in the  
o l d e r  c h i l d r e n .  E b r a h im  h a s  o b s e r v e d  th a t  
v acc ine-in du ced  im m unity  should  be con sid ered  as 
long  term  ra th er than life  long  and co nseq uen tly  if 
there  is a reap p ea ran ce  o f  the d isease  in im m unised  
p o p u la tio n s rev acc in a tio n  shou ld  be c o n s id e re d .11
C O N C L U S IO N
T h e re  is d is tin c t p o ss ib ility  tha t as the  lev e l o f  
im m u n i ty  im p r o v e s  a m o n g  c h i ld r e n ,  d is e a s e  
transm ission  co u ld  sh ift to  y oung  ad u lts  and  o lder 
peop le . In fact a trend tow ards ad u lt m easles  has been 
obse rved  in the U nited  K ingdom . T h e  public  health  
im p lica tion s o f  such  a  sh ift rem ain  u n c lea r bu t it 
cou ld  turn  o u t to b e  d isastrou s p articu la rly  in relation  
to  severity  o f  the d isea se  and  the  e ffec ts  o f  llie d isea se  
on p reg n an t w om en . W h a t a ll th is m ean s is tha t the 
p r e s e n t  im m u n is a t io n  p r a c t ic e  in  d e v e lo p in g  
co u n tries  can n o t in te rrup t m easles  tran sm issio n . To 
w h o l ly  i n t e r r u p t  th e  d i s e a s e  m a y  r e q u i r e  a  
vacc in a tion  reg im e w ith  b ooste rs  (rcvacc in a tion ) to 
en su re  tha t as the y oung  p o p u la tio n  p ro ceed s  into 
adu lth o od  they  a rc  ad equ a te ly  p ro tec ted  from  the 
d isease .
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